MANGALAM.NSE Mangalam Drugs & Organics Ltd.

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Mangalam Drugs & Organics Ltd. market cap is 1.74B.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Mangalam Drugs & Organics Ltd. 52 week high is 132.45 as of July 27, 2024.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Mangalam Drugs & Organics Ltd. 52 week low is 90.80 as of July 27, 2024.

Mangalam Drugs & Organics Ltd. stock price today is 110.35.

Mangalam Drugs & Organics Ltd. stock price yesterday was 109.20.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Mangalam Drugs & Organics Ltd.’s P/E ratio is 0.51.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Mangalam Drugs & Organics Ltd. P/B ratio is 1.3142.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Mangalam Drugs & Organics Ltd.'s EBITDA is 14.31.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Mangalam Drugs & Organics Ltd. 50-day moving average is 106.17.